Your browser doesn't support javascript.
loading
Factors predictive of clinical outcome in advanced hepatocellular carcinoma patients receiving ramucirumab treatment: A real-world experience.
Lin, Po-Ting; Hung, Min-Hua; Shao, Shih-Chieh; Chen, Hui-Yu; Chan, Yuk-Ying; Chang, Kai-Cheng; Lin, Shi-Ming; Ou, Huang-Tz.
Afiliação
  • Lin PT; Department of Gastroenterology and Hepatology, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Hung MH; College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Shao SC; Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University.
  • Chen HY; Department of Pharmacy, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Chan YY; Department of Pharmacy, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan.
  • Chang KC; School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Science, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Lin SM; Department of Pharmacy, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Ou HT; Department of Pharmaceutical Materials Management, Chang Gung Medical Foundation, Taoyuan, Taiwan.
Cancer Med ; 12(14): 14902-14911, 2023 07.
Article em En | MEDLINE | ID: mdl-37278402
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Taiwan
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Taiwan